Cargando…
Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
Lethal toxin (LT) of Bacillus anthracis reduces the production of a number of inflammatory mediators, including transcription factors, chemokines and cytokines in various human cell lines, leading to down-regulation of the host inflammatory response. Previously we showed that the reduction of interl...
Autores principales: | Whiting, Gail, Baker, Michael, Rijpkema, Sjoerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277096/ https://www.ncbi.nlm.nih.gov/pubmed/22347621 http://dx.doi.org/10.3390/toxins4010028 |
Ejemplares similares
-
A Human/Murine Chimeric Fab Antibody Neutralizes Anthrax Lethal Toxin In Vitro
por: Ding, Guipeng, et al.
Publicado: (2013) -
Identification of peptide sequences as a measure of Anthrax vaccine stability during storage
por: Whiting, Gail, et al.
Publicado: (2014) -
Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals
por: Smith, Kenneth, et al.
Publicado: (2021) -
Development of a New Cell-Based AP-1 Gene Reporter Potency Assay for Anti-Anthrax Toxin Therapeutics
por: Ouyang, Weiming, et al.
Publicado: (2023) -
The Receptors that Mediate the Direct Lethality of Anthrax Toxin
por: Liu, Shihui, et al.
Publicado: (2012)